Search

Search Constraints

You searched for: Author/Creator Rottey, Sylvie

Search Results

1. "In‐House" Data on the Outside—A Mobile Health Approach. Issue 4 (7th March 2020)

2. 340 Phase 1 study of AMG 160, a half-life extended BiTE® (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer. (10th December 2020)

3. A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE). Issue 1 (28th January 2019)

4. A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial. (November 2021)

5. A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection. (1st April 2023)

7. An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma. Issue 6 (27th October 2021)

8. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. (January 2022)

9. Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer. Issue 7 (20th December 2013)